- Home
- MYNZ vs BMRA Comparison
MYNZ vs BMRA Comparison
Compare MYNZ & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- BMRA
- Stock Information
- Founded
- MYNZ 2021
- BMRA 1971
- Country
- MYNZ Germany
- BMRA United States
- Employees
- MYNZ N/A
- BMRA N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MYNZ Health Care
- BMRA Health Care
- Exchange
- MYNZ Nasdaq
- BMRA Nasdaq
- Market Cap
- MYNZ N/A
- BMRA 7.4M
- IPO Year
- MYNZ 2021
- BMRA N/A
- Fundamental
- Price
- MYNZ $0.31
- BMRA $0.32
- Analyst Decision
- MYNZ Buy
- BMRA
- Analyst Count
- MYNZ 2
- BMRA 0
- Target Price
- MYNZ $3.00
- BMRA N/A
- AVG Volume (30 Days)
- MYNZ 2.3M
- BMRA 68.2K
- Earning Date
- MYNZ 11-14-2024
- BMRA 10-15-2024
- Dividend Yield
- MYNZ N/A
- BMRA N/A
- EPS Growth
- MYNZ N/A
- BMRA N/A
- EPS
- MYNZ N/A
- BMRA N/A
- Revenue
- MYNZ $917,203.00
- BMRA $5,509,000.00
- Revenue This Year
- MYNZ $36.69
- BMRA N/A
- Revenue Next Year
- MYNZ $91.67
- BMRA N/A
- P/E Ratio
- MYNZ N/A
- BMRA N/A
- Revenue Growth
- MYNZ 16.23
- BMRA 1.74
- 52 Week Low
- MYNZ $0.19
- BMRA $0.24
- 52 Week High
- MYNZ $3.39
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- MYNZ 51.63
- BMRA 47.45
- Support Level
- MYNZ $0.28
- BMRA $0.28
- Resistance Level
- MYNZ $0.33
- BMRA $0.35
- Average True Range (ATR)
- MYNZ 0.05
- BMRA 0.03
- MACD
- MYNZ 0.00
- BMRA 0.00
- Stochastic Oscillator
- MYNZ 42.69
- BMRA 38.50
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.